Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-6-29
pubmed:abstractText
Hematopoietic stem cell (HSC) self-renewal is tightly regulated by a complex crosstalk between many cell-intrinsic regulators and a variety of extrinsic signals from the stem cell niche. In this study, we examined whether the p38 mitogen-activated protein kinase (p38) is one of the intrinsic regulators that can negatively regulate HSC self-renewal in vitro and whether inhibition of p38 activity with a small molecule inhibitor can promote HSC expansion ex vivo. The results from this study showed that sorted mouse bone marrow Lin(-)Sca1(+)c-kit(+) cells (LSK(+) cells) exhibited selective activation of p38 after culture in a serum-free medium supplemented with 100 ng/mL stem cell factor, thrombopoietin, and Flt3 ligand. The activation of p38 was associated with a significant reduction in HSCs and induction of apoptosis and cellular senescence in LSK(+) cells and their progeny. Addition of the specific p38 inhibitor SB203580 (SB, 5 ?M) to the culture inhibited the activation of p38 in LSK(+) cells, which led to increase in HSC self-renewal and ex vivo expansion as shown by the cobblestone area forming cell assay, competitive repopulation, and serial transplantation. The increase in HSC expansion is likely attributable to SB-mediated inhibition of HSC apoptosis and senescence and upregulation of HoxB4 and CXCR4. These findings suggest that p38 plays an important role in the regulation of HSC self-renewal in vitro and inhibition of p38 activation with a small molecule inhibitor may represent a novel approach to promote ex vivo expansion of HSCs.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1557-8534
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1143-52
pubmed:meshHeading
pubmed-meshheading:21198398-Analysis of Variance, pubmed-meshheading:21198398-Animals, pubmed-meshheading:21198398-Apoptosis, pubmed-meshheading:21198398-Cell Aging, pubmed-meshheading:21198398-Cell Culture Techniques, pubmed-meshheading:21198398-Cell Differentiation, pubmed-meshheading:21198398-Cell Growth Processes, pubmed-meshheading:21198398-Cell Proliferation, pubmed-meshheading:21198398-Cell Transplantation, pubmed-meshheading:21198398-Cells, Cultured, pubmed-meshheading:21198398-Enzyme Activation, pubmed-meshheading:21198398-Enzyme Inhibitors, pubmed-meshheading:21198398-Flow Cytometry, pubmed-meshheading:21198398-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:21198398-Hematopoietic Stem Cells, pubmed-meshheading:21198398-Homeodomain Proteins, pubmed-meshheading:21198398-Imidazoles, pubmed-meshheading:21198398-Male, pubmed-meshheading:21198398-Mice, pubmed-meshheading:21198398-Mice, Inbred C57BL, pubmed-meshheading:21198398-Microscopy, Fluorescence, pubmed-meshheading:21198398-Phosphorylation, pubmed-meshheading:21198398-Pyridines, pubmed-meshheading:21198398-Receptors, CXCR4, pubmed-meshheading:21198398-Transcription Factors, pubmed-meshheading:21198398-Up-Regulation, pubmed-meshheading:21198398-p38 Mitogen-Activated Protein Kinases
pubmed:year
2011
pubmed:articleTitle
Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion.
pubmed:affiliation
Department of Pathology, Medical University of South Carolina, Charleston, South Carolina, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural